Objective Masked hypertension (MH) refers to nonelevated office blood pressure (BP) with elevated outof-office BP, but its reproducibility has not been conclusively established. We examined 1-week reproducibility of MH by home BP monitoring (HBPM) and ambulatory BP monitoring (ABPM).
Introduction
Masked hypertension (MH), defined as nonelevated office blood pressure (BP) with elevated average out-ofoffice BP, involves cardiovascular disease (CVD) risk similar to that of sustained hypertension (BP elevated in office and out of office) [1] [2] [3] [4] [5] . Detection of MH requires either ambulatory BP monitoring (ABPM) or home BP monitoring (HBPM) to acquire data for calculating the out-of-office BP average. Given that both methods require resources including equipment and time, it would be valuable to have a strategy for targeting which patients with a nonelevated office BP ought to undergo systematically performed out-of-office BP measurements to detect MH. To be able to predict which patients with nonelevated office BP are more likely to have MH, it is first necessary to demonstrate that the MH classification is reproducible and not merely due to random BP fluctuations [4] .
To date, there are extremely limited data on the reproducibility of MH [6] [7] [8] . Both ABPM and HBPM have been used as out-of-office measurement techniques to classify MH, but they may not be interchangeable for this purpose [8] [9] [10] .
We have previously examined the short-term reproducibility of MH among a sample of 50 adults with a 'borderline' office BP measurement [8] . Among this sample, prevalence rates of MH based on office-awake ABPM pairings were 54 and 53%, with an agreement of 73% [κ = 0.47; 95% confidence interval (CI) 0.21-0.72]. MH was less prevalent (43 and 35%) using HBPM-office pairings, with an agreement of 69% (κ = 0.34; 95% CI 0.06-0.62). Office-HBPM pairings and office-awake ABPM pairings had poor agreement on MH classification on both occasions, with κ-values of − 0.06 and 0.10, respectively. Given the uncertainty in our prior estimates, we undertook a large-scale study to quantify the reproducibility of MH and the agreement between home and ABPM methods.
Methods

Study recruitment and setting
Our sample size of 420 adults was based on the power to rule out κ-values less than or equal to 0.35 if the true magnitude of κ in the target population is ∼ 0.50 or greater, taking into account the possible loss of 20 participants. We posted signs in seven primary care clinics inviting people with a recent office (clinic) BP measurement that was 'borderline' or 'a little high' to participate. Individuals interested in participating contacted a study coordinator to confirm eligibility and schedule their study visits. Study coordinators also recruited potentially eligible participants through review of their vital signs documented in electronic medical records during their most recent primary care clinic visit. To be eligible, a person had to be 30 years of age or older, have a primary care clinician, and be on no BP-lowering medications. The most recent primary care clinic visit BP had to be between 120 and 149 mmHg systolic or 80 and 95 mmHg diastolic, with neither greater than 149 /95 mmHg. Exclusion criteria were pregnancy, dementia, any condition that would preclude wearing an ambulatory BP monitor, and persistent atrial fibrillation or other arrhythmia. We also excluded potential enrollees if initial office BP at research visit 1 was 160/100 mmHg or higher, or less than 110/70 mmHg, as such participants would be more likely to have sustained hypertension or sustained normotension, respectively. All study procedures took place in a clinical research center.
Office blood pressure
Following check-in procedures at visits 1 through 4, participants were placed in an exam room in the clinical research center. After at least 5 min of rest, same arm BP was measured three times using a validated [11] office-type oscillometric device (Welch Allyn Vital Signs, Skaneateles Falls, NY, USA) according to recommended timing and positioning and using the appropriate BP cuff size. The second and third measurements were averaged to determine the participant's office BP measurement for the visit.
We included patients with initial office BPs of 140/90 mmHg or higher to be able to account for the possibility that some people classified as having sustained hypertension or white-coat hypertension at one time may be classified as having MH or another hypertension variant at a different time [6] . Only by allowing people with an elevated office BP to participate could that possibility be examined.
Ambulatory blood pressure monitoring
Participants underwent two 24-h ABPM sessions 1 week apart using the Oscar 2 oscillometric monitor (Suntech Medical, Morrisville, North Carolina, USA). The Oscar 2 has been validated for use in adults by both the British Hypertension Society protocol and the International Protocol for the validation of BP measuring devices [12, 13] . The monitors were programmed to measure BP at 30-min intervals from 6 a.m. to 10 p.m. and at 1-h intervals from 10 p.m. to 6 a.m. For the first 143 participants, we defined the awake period as 10 a.m. to 10 p.m. and sleep period as midnight to 6 a.m. For participants 144 through 420, we incorporated a participant diary and used it to define sleep and awake periods. Maximum BP measurement time was limited to less than 140 s, and the monitors were set for a maximum pressure of 220 mmHg. Participants were given verbal instructions on wearing the monitor, which included leaving the cuff on during the entire monitoring period and holding their cuffed arm as still as possible during a reading to ensure that the monitor would get an accurate reading; they were also informed that cuff inflation would cause a tight feeling around the arm and that faulty readings would trigger a repeat measurement. The minimum number of readings we accepted as an adequate ABPM session was 14 for awake and six for sleep.
Home blood pressure monitoring
At the second study visit, participants were instructed on how to correctly perform home BP measurements using an Omron 705 CP home BP monitor. The Omron 705 CP monitor (Omron Healthcare, Lake Forest, IL, USA) has been previously validated [14] . Between the second and third visits and between the fourth and fifth visits, such a home monitor was loaned to participants, and they were asked to conduct home BP measurements on five consecutive days, with three measurements taken in the morning and three measurements taken in the evening. Participants were instructed that these measurements were to be performed in the sitting position after 5 min of rest, with 1 min between measurements. Participants were asked to record dates, times, and BP measurements on a preprinted form. The HBPM average was calculated by discarding the measurements taken on the first 2 days and the first measurement of each triplicate set of measurements and averaging the remaining 12 measurements [15] . Only participants with measurements taken on all 5 days were included in home BP analyses.
Other variables
Height and weight were measured at the first study visit and used to calculate BMI. Arm circumference at midbiceps was measured at the first study visit and used to guide BP cuff size. Information on demographics and medical history was collected through a self-administered questionnaire.
Analysis MH based on awake ABPM was defined as an office BP average of less than 140/90 mmHg at a preceding visit, with either a mean awake ABPM systolic BP of 135 mmHg or higher, or a mean awake ABPM diastolic BP of 85 mmHg or higher [16] . MH based on HBPM was defined as an office BP average of less than 140/90 mmHg at a preceding visit, with either a mean home systolic BP of 135 mmHg or higher, or a mean home diastolic BP of 85 mmHg or higher [16] . The home BP prevalence and reproducibility analyses were repeated using a lower home BP systolic BP threshold of 130 mmHg or higher [17] . MH based on 24-h BP monitoring was defined as a preceding office BP average of less than 140/90 mmHg, with either a mean 24-h ambulatory systolic BP of 130 mmHg or higher, or a mean 24-h diastolic BP of 80 mmHg or higher [16] . We calculated the percentage agreement for the classification of MH on the basis of ABPM-office pairings between the first and second sets of measurements. We calculated the percentage agreement for the classification of MH on the basis of home BP-office BP pairings between the first and second sets of measurements. We also calculated the agreement between different out-of-office measurement methods at each time period. Agreement was quantified using the κ-statistic, its 95% CI, and P-value [18] . We defined a comparison 'gold standard' of MH as MH present by 24-h ABPM-office BP pairings at both sessions and calculated the prevalence of MH on the basis of this definition. We carried out sensitivity analyses by repeating the above analyses using an office average of 130/85 mmHg (rather than 140/90 mmHg) as the cutoff for elevated office BP. This analysis also serves to address the issue of whether classification of MH is largely based on measurements that vary only slightly around the cutoffs (which would be more likely due to random variation as opposed to systematic variation).
We repeated the prevalence calculations using each participant's eligibility BP (the measurement performed in their actual clinical setting) paired with the first ABPM session. We also repeated the prevalence and reproducibility calculations after eliminating the possible 'whitecoat' period (first 2 h) of the ABPM sessions. Finally, we compared the agreements of MH between participants for whom we used a sleep diary and those for whom we used time-based sleep periods. Analyses were carried out using SAS 9.3 (SAS Institute Inc., Cary, North Carolina, USA).
Study approval
This study was approved by the Office of Human Research Ethics at the University of North Carolina at Chapel Hill.
Results
Participant characteristics
The mean SD age of the 420 participants was 48 12 years. Most participants were between 45 and 64 years (46%) or between 30 and 44 years (43%; Table 1 ). Slightly more than half were female. Approximately 21% were Black. Only nine participants did not have sufficient awake ABPM readings at the first session, and 13 did not have sufficient awake ABPM readings at the second session. Eighty-one participants did not conduct sufficient home BP measurements during the first interval, and 86 participants did not conduct sufficient home BP measurements during the second interval.
Blood pressures
The mean eligibility BP for the participants was 134 /79 11/9 mmHg. Research visit office BP average was 140 mmHg or higher systolic and 90 mmHg or higher diastolic for 28% of participants at visit 1, 29% of participants at visit 2, 27% of participants at visit 3, and 25% of participants at visit 4. The mean SD office BP average for participants at the first office visit was 130/81 13/9 mmHg ( Fig. 1 ). The first set of average awake ambulatory BP values ranged from 113/61 to 197/118 mmHg, with a mean of 142/84 14/9 mmHg. Home BP averages from the first set of sessions ranged from 100/58 to 165/108 mm Hg, with a mean of 127/79 11/8 mmHg. The mean SD office BP average of participants at the third measurement session was 129/81 13/9 mmHg. The second set of average awake ambulatory BP values ranged from 109/60 to 189/115 mmHg, with a mean of 141/84 13/9 mmHg. Home BP averages in the second set of sessions ranged from 102/56 to 169/106 mmHg, with a mean of 128/80 11/8 mmHg. Prevalence of masked hypertension in the study sample
Using the office BP average paired with the awake ABPM average that immediately followed, the prevalence of MH based on the first set of measurements was found to be 44% (95% CI 39-49%) and that based on the second set of measurements was found to be 43% (95% CI 38-48%; Table 2 ). When considering the entire 24 h of ABPM measurements, the prevalence of MH based on the first set of measurements was 50% (95% CI 45-55%) and based on the second sets of measurements was 48% (95% CI 43-53%). The prevalence of MH based on two 'positive' 24-h ABPM-office BP average pairings was 33% (95% CI 28-37%). Among those with a 'normal' (< 140/90 mmHg) preceding office BP, 69.4% (95% CI 64.1-74.7%) had MH on the basis of the first 24-h ABPM, and 65.9% (95% CI 60.5-71.3%) had MH on the basis of the second 24-h ABPM.
Using a home BP threshold of greater than 135/85 mmHg, the prevalence of MH based on the series of home BP measurements paired with the office BP average at the preceding visit was 15% (95% CI 11-19%) by the first set of measurements and 17% (95% CI 13-21%) by the second set of measurements. Using the lower home systolic BP threshold of greater than 130 mmHg, the prevalence of MH was 24.0% (95% CI 19.5-28.6%) by the first set of measurements and 25.5% (95% CI 20.8-30.2%) by the second set of measurements.
Reproducibility of masked hypertension classification
When estimated on two different occasions and paired with the corresponding office BP average, the awake ABPM average was concordant in classifying participants 71% of the time, with a κ-value of 0.40 (95% CI 0.31-0.49; Table 3 and Fig. 2 ). MH classification based on pairings of the HBPM average with the office BP average at the preceding visit was in agreement 82% of the time, with a κ-value of 0.30 (95% CI 0.16-0.44). During both time periods, HBPM-office pairings had fair agreement with awake ABPM-office pairings in classifying participants (κ = 0.36 and 0.30). Awake ABPM was highly concordant with 24-h ABPM in classifying participants at both time periods (92 and 94%).
Sensitivity analysis
Using an office average of less than 130/85 mmHg paired with an awake ABPM average of 135/85 mmHg or higher, 98 of 408 participants (24%) still had MH at the first session, and 82 of 406 (20%) had MH at the second session. The agreement between the two sessions using this office threshold was 74% (κ = 0.25; 95% CI 0.14-0.35). Using the lower office threshold paired with home BP averages, the prevalence rates of MH were 5 and 7%, with 91% agreement (κ = 0.23; 95% CI − 0.04 to 0.43). Office-home pairing and office-awake ABPM pairing had 83% concordance the first time (κ = 0.29; 95% CI − 0.17 to 0.41) and 83% concordance the second time (κ = 0.31; 95% CI − 0.18 to 0.43). 
Sustained hypertension
Prevalence of blood pressure classifications at baseline and 1 week later. On the basis of the first 24-h ABPM session and its preceding office visit BP average, the prevalence of MH was 49.8%. Among these participants, 66% had MH at repeat monitoring 1 week later. ABPM, ambulatory blood pressure monitoring; BP, blood pressure; MH, masked hypertension.
Among participants whom we classified on the basis of time periods alone, the agreement of MH using the 24-h ABPM average was 65.2%, with a κ-value of 0.30 (95% CI 0.14-0.46). Among those for whom we had a sleep diary, the agreement of MH was 69.3%, with a κ-value of 0.39 (95% CI 0.28-0.50). When defining ABPM on the basis of the awake ABPM average, the agreement was 67.4% (κ = 0.33; 95% CI 0.17-0.49) among those without a diary and 72.1% (κ = 0.44; 95% CI 0.33-0.55) among those with a diary.
Out-of-office reproducibility following single clinical office blood pressure measurement On the basis of the eligibility-visit office BP (before any measurements were taken in the research setting), 263 participants had nonelevated BP (< 140/90 mmHg). The first awake ABPM session revealed elevated BP in 156 of these participants (59%), and the second ABPM session revealed elevated BP in 161 of them (61%), with an agreement of 82% (κ = 0.61, 95% CI 0.51-0.71). The first HBPM series of measurements revealed elevated BP in 41 of these participants with 'normal' office BP, and the second HBPM series revealed elevated BP in 49 of them. The agreement between home measurements among these participants was 84% (κ = 0.50, 95% CI 0.35-0.66).
Eliminating the white-coat period from ambulatory blood pressure monitoring After eliminating the first 2 h from each participant's ABPM sessions, 176 of 408 (43%) still had MH at the first session, and 172 of 406 (42%) had MH at the second session. The agreement between the two sessions was 72% (κ = 0.43; 95% CI 0.34-0.52). Using these averages, the agreement between MH based on awake ABPM and HBPM were 72% at the first session (κ = 0.35) and 69% at the second session (κ = 0.30).
Discussion
We have previously reported, based on a sample of 50 adults, that the short-term reproducibility of MH is fair to moderate [8] . The current study affirms our finding that the MH classification is reproducible. We again found fair agreement in the short-term reproducibility of MH when measured in terms of office BP and ambulatory BP average pairings and in terms of office BP and HBPM average pairings.
There are few other published studies on the reproducibility of MH in adults. One study examined this issue using a database of 196 patients who had undergone repeated ABPM for clinical indications (e.g. suspected white-coat hypertension) [6] . At the first ABPM session, 25 (13%) were classified as having MH. Upon remonitoring, 11 of the 25 still had MH, whereas seven had sustained hypertension, five had true normotension, and two had white-coat hypertension. One person with whitecoat hypertension at the first monitoring session had MH on remonitoring. Overall κ was reported as 0.26. Of note, most of the patients (80%) were already receiving antihypertensive treatment. Antihypertensive medications could also have been added or adjusted between monitoring sessions. In addition, the average time between the two monitoring sessions was 1.5 1.5 years. Patients' office and/or mean ambulatory BPs could change substantially over that length of time, influenced not only by factors such as medication changes but also, as the authors themselves pointed out, physical activity and weight changes.
Another study reported the reproducibility of MH among a group of 503 Japanese workers who were not under treatment for hypertension [7] . The reproducibility of MH was 59% (κ =0.58) over a 6-month period using morning HBPM for the out-of-office measurements. However, in addition to the 6-month time period, this study had other notable limitations. The office BP measurement used could have been taken as long as 1 month before or after the out-of-office monitoring. Further, because the office measurements were taken by physicians, the white-coat effect may have be greater than if measurements were taken by a nurse or medical assistant using an automatic oscillometric monitor.
In our study, the higher prevalence of MH detected by ABPM compared with HBPM may be due to factors that contribute to elevated out-of-office BP observed outside of home life. Assuming that ABPM is the 'gold standard' technique for diagnosing MH, an elevated average BP on home monitoring may be sufficient to rule in MH (adequate specificity), but a nonelevated average on HBPM does not rule out MH (poor sensitivity). Others have reached similar conclusions [19] .
In sensitivity analyses using a 10/5 mmHg lower office BP cutoff paired with elevated out-of-office measurements to define MH, the prevalence rates of MH were lower (as expected), but the agreement levels were similar. These analyses highlight that MH is not merely a classification ascribed to small fluctuations in BP around borderline threshold levels. For some people, the out-ofoffice BP average is substantially (e.g. 20 mmHg systolic) higher than office BP. Such differences may equal a doubling of CVD risk [20] .
We also found that agreement is improved when awake and sleep periods are defined by a diary rather than time periods. Although several studies in the literature [21, 22] use defined time periods, this finding suggests that the diary approach is preferred.
We also examined the prevalence of MH using the participants' most recent clinic BP rather than their research office visit BPs. Again, the prevalence of MH was high. Therefore, the high prevalence of MH and the agreement levels that we found were not merely reflections of slightly lower BPs attained in research office settings [23] .
Our prevalence estimates should not be construed to represent prevalence of MH in adults in the general population or in the primary care population. Rather, they represent the high pretest probability of MH among patients seen in the office with BPs in the prehypertension range. Our findings are similar to the findings of other investigators. Shimbo et al. [24] found a prevalence of MH of 34% among a community sample of adults with prehypertension. Among the subset with BP in the 130-139/85-89 mmHg range, prevalence of MH was 52%, providing additional evidence for the high pretest probability of MH among people with BP in the upper prehypertension range.
Interestingly, we found a low prevalence of white-coat hypertension in our study sample, reflecting the higher averages from ABPM compared with office BP measurements, as shown in Fig. 1 . With an average awake ambulatory BP that is 15 mmHg higher than the office BP average, there will be few patients among those with office systolic BPs between 140 and 150 mmHg who will have awake ambulatory BPs less than 135/85 mmHg.
Our study population was generally healthy and therefore might not be representative of the general population. With regard to the HBPM, we note limitations as well. We did not use the same device for office measurements and home BP measurements. We also relied on participants' written reports of their home BPs, which may have been inaccurate. However, we did perform checks of reports against the home BP device memory.
Our consistent finding that MH has fair short-term reproducibilitywhich is comparable in our data to the reproducibility of the other classificationssupports the hypothesis that there are factors other than random BP variability that explain the MH phenotype. On the one hand, there may be factors that cause people's BP to be higher outside the office setting. For example, work stress, home strain, trait-anger, and high stress in general may all lead to BP elevations that are diminished when a person is sitting in a healthcare provider's office [24] [25] [26] [27] [28] . Other factors that transiently raise BP, such as smoking, may contribute to an elevated out-of-office BP average that is not detected in a clinical setting because of the time refraining from them before and during a clinic visit [4, 29, 30] . On the other hand, it is also possible that there are factors specifically attributable to being in the office setting that lead to a measured BP that is lower than the person's 'average' BP. ABPM measures BP in people's natural environments. It is possible that the long-standing paradigm of measuring someone's BP only when they are at rest and in a comfortable setting does not accurately reflect the BP that the target organs see every day. This difference between office BP and ambulatory BP may explain ABPM's better predictive ability [31] .
Conclusion
MH represents a common and reproducible BP phenotype.
Future research should seek to identify factors consistently associated with MH, with a goal of helping clinicians decide which patients with a nonelevated office BP should be considered for out-of-office BP monitoring. Further study is also needed to determine whether treatment of MH, which would have to be guided by out-of-office BP measurements, leads to reduced CVD events.
